Published: May 2013
ACE Report #5081
Ace Report Cover Osteoarthritis

Tocilizumab more effective in reducing rheumatoid arthritis symptoms than adalimumab

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Lancet. 2013 May 4;381(9877):1541-50. doi: 10.1016/S0140-6736(13)60250-0. Epub 2013 Mar 18

Contributing Authors: C Gabay P Emery R van Vollenhoven A Dikranian R Alten K Pavelka M Klearman D Musselman S Agarwal J Green A Kavanaugh ADACTA Study Investigators

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.